UiPath (NYSE:PATH) rebound erases OpenAI Presence selloff, but ARR math sets next test

UiPath shares finished Tuesday at $12.19, up 4.9% and hitting $12.24 at their session high. Volume for the day totaled 46.8 million shares. The most recent press release on the official newsroom was the Maestro Case update published June 16. With no new company announcement to account for the rise, short covering is considered a potential driver. UiPath

UiPath’s fiscal second quarter concludes on July 31. The company projects revenue in the range of $395 million to $400 million, with ARR expected to end up between $1.929 billion and $1.934 billion. UiPath’s non-GAAP operating income is forecast around $75 million. At the midpoint, these projections suggest about 9.8% revenue growth and 12.1% ARR growth. The firm has not yet provided a reporting date. Third-party calendars currently list September 3 as the expected date. UiPath, Inc.

UiPath reported first quarter revenue of $418 million, surpassing its earlier forecast by $18 million. Annualized recurring revenue (ARR) came to $1.901 billion, exceeding guidance by around $2 million. The company lifted its full-year revenue outlook by about $22 million at the midpoint, setting the new forecast at $1.776 billion to $1.781 billion. This projects growth of 10.3% to 10.6% from fiscal 2026. Guidance for non-GAAP operating income was also increased by $15 million, now expected at roughly $430 million. UiPath, Inc.

While evidence is strengthening, financial disclosure gaps persist. Management reported that AI features were present in 16 of UiPath’s 20 largest Q1 transactions. UiPath also notes that agentic products are advancing from pilot stages to active deployment. Standalone agentic revenue and ARR remain undisclosed. Growth among major accounts provides some indirect indication. The number of customers with more than $1 million in ARR increased to 374, up from 316. SiliconANGLE

ARR increased by 12% to $1.901 billion, as dollar-based net retention stood at 109%, compared with 108% in the previous year. UiPath reported 2,624 customers generating over $100,000 in ARR, up from 2,365. These customers accounted for 87% of revenue for the quarter. Clients with ARR above $1 million contributed 52% of total revenue. Revenue concentration continues to rise, though no individual customer represented more than 10%. UiPath, Inc.

Q1 GAAP operating income totaled $28 million, compared to a loss of $16 million a year earlier. On a non-GAAP basis, operating income stood at $92.5 million for a 22% margin. Adjusted free cash flow climbed to $130.3 million from $117.1 million. Stock-based compensation declined to $53.3 million from $76.4 million, still representing roughly 13% of revenue. The company expects its full-year non-GAAP operating margin to be around 24%. UiPath, Inc.

UiPath repurchased 20.4 million shares for $243.8 million in Q1, with an average price of $11.47 per share. By May 15, it had acquired another 2.4 million shares at an average of $9.63 each. As of April 30, $436.9 million remained available under the repurchase program. At a share price of $12.19, this could retire close to 36 million shares. The company held $1.416 billion in cash and securities at the end of the quarter. The timing and pricing of actual buybacks remain at UiPath’s discretion and may differ. UiPath, Inc.

According to exchange figures, short interest stood at 112.9 million shares as of July 15. Data providers estimate this to be nearly 28% of the float, though float definitions differ. Short positions declined by 18.7% from the previous reading. Days to cover remained low at around 1.4, with trading volume remaining elevated. This environment can heighten rallies if bearish investors move quickly to cover but may also speed up reversals if momentum weakens. MarketBeat

The market capitalisation stands at around $6.43 billion. After deducting April cash and securities, the cash-adjusted figure is about $5.0 billion. This estimate does not include lease obligations or possible acquisition-related payments. The result is approximately 2.8 times the midpoint of fiscal 2027 revenue guidance. Analysts remain cautious overall. Consensus price targets currently fall between $13.25 and $14.07, depending on the analyst coverage. UBS most recently set its target at $12 and assigned a Neutral rating. UiPath, Inc.